StockNews.com lowered shares of Adient (NYSE:ADNT - Free Report) from a buy rating to a hold rating in a research report released on Friday.
A number of other research analysts also recently issued reports on ADNT. Morgan Stanley dropped their price objective on Adient from $19.00 to $17.00 and set an "underweight" rating on the stock in a research note on Monday, March 3rd. Bank of America downgraded shares of Adient from a "neutral" rating to an "underperform" rating and reduced their price objective for the stock from $24.00 to $18.00 in a research report on Tuesday, March 4th. Barclays downgraded shares of Adient from an "equal weight" rating to a "negative" rating in a research report on Tuesday, April 15th. UBS Group reduced their price target on shares of Adient from $20.00 to $13.00 and set a "neutral" rating for the company in a report on Thursday, April 10th. Finally, JPMorgan Chase & Co. cut their price objective on shares of Adient from $24.00 to $21.00 and set a "neutral" rating on the stock in a research report on Monday, January 27th. Three research analysts have rated the stock with a sell rating and eight have issued a hold rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $18.44.
Check Out Our Latest Stock Analysis on Adient
Adient Trading Up 4.2 %
ADNT traded up $0.50 during midday trading on Friday, hitting $12.51. 521,972 shares of the company were exchanged, compared to its average volume of 1,396,054. Adient has a 1-year low of $10.04 and a 1-year high of $31.19. The company has a quick ratio of 0.86, a current ratio of 1.08 and a debt-to-equity ratio of 1.11. The firm has a market capitalization of $1.05 billion, a P/E ratio of 625.50, a P/E/G ratio of 0.34 and a beta of 1.97. The firm's 50 day moving average price is $13.77 and its 200-day moving average price is $17.12.
Adient (NYSE:ADNT - Get Free Report) last released its quarterly earnings results on Tuesday, January 28th. The company reported $0.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.32 by ($0.05). Adient had a positive return on equity of 6.94% and a negative net margin of 0.01%. During the same quarter in the prior year, the business posted $0.31 EPS. As a group, equities analysts forecast that Adient will post 1.76 EPS for the current fiscal year.
Institutional Trading of Adient
Institutional investors and hedge funds have recently modified their holdings of the stock. Pzena Investment Management LLC raised its position in Adient by 28.5% in the 4th quarter. Pzena Investment Management LLC now owns 3,629,452 shares of the company's stock valued at $62,535,000 after buying an additional 803,961 shares during the last quarter. Arrowstreet Capital Limited Partnership purchased a new stake in shares of Adient in the fourth quarter valued at about $11,395,000. Millennium Management LLC lifted its position in shares of Adient by 2,039.0% during the fourth quarter. Millennium Management LLC now owns 610,312 shares of the company's stock valued at $10,516,000 after purchasing an additional 581,779 shares in the last quarter. HITE Hedge Asset Management LLC boosted its holdings in Adient by 122.4% during the fourth quarter. HITE Hedge Asset Management LLC now owns 816,286 shares of the company's stock worth $14,065,000 after purchasing an additional 449,272 shares during the last quarter. Finally, JPMorgan Chase & Co. grew its position in Adient by 96.5% in the 4th quarter. JPMorgan Chase & Co. now owns 802,540 shares of the company's stock worth $13,828,000 after purchasing an additional 394,111 shares in the last quarter. 92.44% of the stock is owned by hedge funds and other institutional investors.
Adient Company Profile
(
Get Free Report)
Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.
Featured Stories

Before you consider Adient, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Adient wasn't on the list.
While Adient currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.